Alopecia areata Trials in Irvine, United States
Conditions / Alopecia areata / Irvine, United States
Clinical trials for Alopecia areata investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03898479 | Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT04784533 | A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata | COMPLETED | PHASE2 |
| NCT06012240 | A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata | RECRUITING | — |
| NCT06444451 | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04006457 | Long-Term PF-06651600 for the Treatment of Alopecia Areata | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04518995 | Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) | COMPLETED | PHASE3 |
| NCT03570749 | A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata | COMPLETED | — |
| NCT03661866 | A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC | RECRUITING | — |
| NCT03732807 | PF-06651600 for the Treatment of Alopecia Areata | COMPLETED | PHASE2/PHASE3 |
| NCT03570749 | A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata | COMPLETED | — |